# Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: Mirum Pharmaceuticals, Inc. · Condition: Alagille Syndrome

- Company: Mirum Pharmaceuticals, Inc.
- Sector: rare disease
- Primary source: https://clinicaltrials.gov/study/NCT07290257

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.